ALK Abello
3.3.2021 17:07:03 CET | Globenewswire | Press release
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) reports the following transactions:
| 1. | Details of the person discharging managerial responsibility / person closely associated | ||
| a) | Name | Carsten Hellmann | |
| 2. | Reason for the notification | ||
| a) | Position/status | President & CEO | |
| b) | Initial notification/ amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | ALK-Abelló A/S | |
| b) | LEI | 529900SGCREUZCZ7P020 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument: (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument Identification code | Shares DK0060027142 | |
| b) | Nature of the transaction | Sale | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| DKK 2,600 | 5,000 | ||
| d) | Aggregated information - Aggregated volume - Price | 5,000 DKK 13,000,000 | |
| e) | Date of the transaction | 2021-03-03 | |
| f) | Place of the transaction | Nasdaq Copenhagen | |
ALK-Abelló A/S
For further information please contact:
Investor Relations: Per Plotnikof, mobile +45 2261 2525
Media: Jeppe Ilkjær, mobile +45 3050 2014
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Alkane Resources Limited30.3.2026 00:16:17 CEST | Press release
Alkane Executes $110 Million Revolving Credit Facility
Fast Ejendom Danmark29.3.2026 18:17:55 CEST | Pressemeddelelse
Aktietilbagekøbsprogram
Newcap Holdings29.3.2026 12:19:20 CEST | Pressemeddelelse
NewCap Holding A/S har indgået en aftale, betinget af underskrivelse af endelige aftaledokumenter m.v., om erhvervelse af dansk selskab indenfor compliance og risikostyringsservices – Intern viden
Novartis Pharma AG29.3.2026 07:15:00 CEST | Press release
Novartis IgAN data in New England Journal of Medicine show Fabhalta® slowed kidney function decline by 49.3%
Biogen Inc.28.3.2026 20:00:00 CET | Press release
Biogen Announces Second Positive Phase 2 Litifilimab Trial in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting, Showing a Significant Reduction in Skin Disease Activity
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
